Basic Mirtazapine Information

• INN (International Nonproprietary Name): Mirtazapine
• Brand Names Available In Australia: Avanza (tabs: 15 mg, 30 mg, 45 mg); generics widely supplied by manufacturers such as Teva, Sandoz, Sun Pharma and others.
• ATC Code: N06AX11
• Forms & Dosages: Tablets 7.5 mg (rare), 15 mg, 30 mg, 45 mg; Orodispersible tablets 15 mg, 30 mg, 45 mg; oral solution not universally available.
• Manufacturers In Australia: Organon (originator), Teva, Sandoz, Sun Pharma, Mylan and other regional generic producers are listed as global suppliers and local repackagers.
• Registration Status In Australia: TGA-approved for major depressive disorder and marketed locally (commonly as Avanza); prescription-only (S4).
• OTC / Rx Classification: Prescription Only (Rx).

Major 2022–2025 Australian And Global Studies

Which recent trials matter for patients and prescribers?

Recent research from 2022 through mid-2024 converges on two clear trends for mirtazapine.

First, mirtazapine retains consistent effectiveness for major depressive disorder (MDD) in randomised controlled trials and meta-analyses, with overall remission rates at 6–12 weeks comparable to many SSRIs.

Second, investigators increasingly study symptomatic indications such as insomnia and appetite stimulation in oncology and palliative care, where the drug’s sedative and orexigenic effects are useful.

Australian pharmaco-epidemiology analyses of PBS dispensing from 2021–2023 show steady prescribing volumes, with higher use in older adults and frequent co-prescription where insomnia is present.

International RCTs and pooled analyses through 2023 continue to show a rapid sedative onset compared with several SSRIs and a comparatively favourable sexual side-effect profile, driving niche prescribing among patients concerned about libido.

Main Outcomes

What benefits do trials show and when do they appear?

Studies report faster improvement in sleep and early mood symptoms within 1–2 weeks compared with some SSRIs, making mirtazapine attractive when insomnia is prominent.

Overall remission and response at 6–12 weeks are broadly comparable to SSRIs and other antidepressants for many patients with MDD.

Weight gain and somnolence are consistent trade-offs reported across trials and real-world datasets, often appearing within weeks to months of starting therapy.

Safety Observations (TGA Reports)

What safety signals should prescribers and pharmacists watch for?

The TGA and international pharmacovigilance bodies flag sedation and falls in older adults as the main practical safety concerns.

Rare haematologic events such as blood dyscrasias have been reported and are listed in post-market data, although these remain uncommon.

No new class-wide mortality signals have emerged in the 2022–2024 period according to available regulatory summaries.

Layman’s Explanation

What does mirtazapine do in simple terms?

Mirtazapine helps rebalance brain chemicals that influence mood, sleep and appetite.

When taken at night, its sedating effect can ease insomnia and help people sleep earlier in treatment than with many SSRIs.

Its appetite-stimulating properties can help people who are losing weight due to illness, such as some oncology or palliative care patients.

Scientific Breakdown

How does mirtazapine work, scientifically?

Mirtazapine is classified under ATC code N06AX11 as a tetracyclic antidepressant in the "other antidepressants" group.

It antagonises central presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, which increases noradrenergic and serotonergic neurotransmission.

It blocks 5-HT2 and 5-HT3 serotonin receptors and strongly antagonises H1 histamine receptors.

The H1 blockade largely explains early sedation and appetite increase, while 5-HT2/5-HT3 antagonism tends to reduce sexual side effects and nausea compared with many SSRIs.

Receptor Profile Implications

Why do these receptor effects matter in practice?

5-HT2 and 5-HT3 antagonism is associated with fewer sexual side effects and less nausea than is typical with SSRI therapy.

Strong H1 antagonism is the primary driver of early somnolence and an increased appetite leading to weight gain.

Because mirtazapine has minimal direct serotonin reuptake inhibition, some SSRI-type adverse effects are less prominent.

Australian Approvals (TGA-Listed, PBS Inclusion)

Is mirtazapine approved and subsidised in Australia?

Mirtazapine is TGA-approved in Australia for major depressive disorder and is marketed locally under brand names such as Avanza in 15 mg, 30 mg and 45 mg tablets.

It is prescription-only (S4) and appears in PBS prescribing datasets, though PBS subsidy eligibility depends on clinical criteria and prescriber authority.

Clinicians must document PBS criteria when issuing a subsidised script.

Notable Off-Label Trends In Australian Practice

How do clinicians use mirtazapine beyond the label?

Clinicians frequently use mirtazapine off-label for insomnia in people with depressive symptoms, often prescribing a low nocturnal dose to harness sedative benefits while limiting daytime drowsiness.

It is also used to stimulate appetite in oncology and palliative care and for persistent nausea where 5-HT3 antagonism is helpful.

In primary care and aged-care settings, prescribers favour mirtazapine for depression with insomnia or where sexual side effects from SSRIs are undesirable.

Specialist input is advised for paediatric use or situations with bipolar disorder risk.

General Dosing

What doses should patients expect?

Standard adult dosing for MDD is 15–45 mg once daily at bedtime.

Many clinicians start at 15 mg at night and consider titrating to 30–45 mg over 1–2 weeks if response is insufficient and tolerability allows.

Lower starting doses, such as 7.5–15 mg at night, are common where sedation or orthostatic risk is a concern.

Orodispersible and film-coated formulations are available in 15 mg, 30 mg and 45 mg strengths; 7.5 mg tablets are uncommon.

Condition-Specific Dosing (PBS Recommendations)

How is dosing tailored for specific situations?

For depression, start at 15 mg at night and titrate to 30–45 mg over 1–2 weeks if needed, balancing benefit and sedation.

When insomnia predominates, some clinicians maintain a 15 mg nocturnal dose to retain sedative benefit and limit daytime somnolence.

For appetite stimulation or palliative settings, 7.5–15 mg may be sufficient and is often titrated for effect.

In older adults start at 7.5–15 mg and increase cautiously while monitoring for falls and orthostatic hypotension.

In liver impairment begin at a low dose and titrate slowly due to increased circulating levels.

Contraindications (Australian Guidelines)

Who must not take mirtazapine?

Absolute contraindications include known hypersensitivity to mirtazapine or any excipients and concurrent or recent (within 14 days) monoamine oxidase inhibitor (MAOI) therapy.

Caution is required for people with bipolar disorder because of mania risk, those with seizure history, severe hepatic or renal impairment, recent myocardial infarction, and those with glaucoma or prostatic hypertrophy due to anticholinergic effects.

Adverse Effects (Post-Market Pharmacovigilance)

What side effects are commonly reported?

Common adverse effects are somnolence, increased appetite and weight gain, dry mouth, dizziness, constipation and fatigue.

Moderate or rare events include peripheral oedema, vivid dreams, blood dyscrasias (rare — monitor a complete blood count if symptomatic) and transaminase elevations.

The TGA and other agencies emphasise fall risk in older adults due to sedation and orthostatic hypotension; counsel patients and consider dose reduction where appropriate.

Food Interactions (Alcohol, Coffee, Diet In Australia)

How do everyday substances interact with mirtazapine?

Alcohol has additive central nervous system depression with mirtazapine, increasing sedation and injury risk, so avoidance or minimisation is advisable.

Caffeine may counteract the sedative benefit but does not cause major pharmacokinetic interactions with mirtazapine.

High-calorie diets combined with mirtazapine frequently accelerate weight gain, a practical concern in many Australian dietary patterns.

Drug Combinations To Avoid (TGA Safety Alerts)

Which medicines are incompatible with mirtazapine?

MAOIs are an absolute contraindication — allow a 14-day washout when switching classes.

Use caution and monitor when combining with other serotonergic agents such as SSRIs, SNRIs and triptans because of the low-to-moderate risk of serotonin syndrome.

Additive sedatives like benzodiazepines and opioids increase respiratory depression and fall risk and should be used carefully.

Although many CYP450 interactions are modest with mirtazapine, exercise caution with strong inhibitors or inducers and consult product information for specifics.

Australian Survey Data

What do patients say about taking mirtazapine?

Real-world Australian patient surveys and PBS dispensing analyses show two dominant narratives.

One group reports earlier symptomatic relief and improved sleep when mirtazapine is prescribed for depression with insomnia.

The other major theme is noticeable weight gain within weeks to months, which affects adherence and treatment satisfaction.

Older patients generally appreciate sleep benefits but frequently report daytime sedation and concerns about falls.

Forum And Pharmacy Trends

What do community pharmacists and forums report?

Pharmacists in national chains and independent stores commonly focus counselling on bedtime dosing, morning sedation risk, weight and diabetes counselling, and alcohol interactions.

Online forums often praise improved sleep and less sexual dysfunction compared with SSRIs, while negative experiences centre on weight gain and morning grogginess.

In rural Australia access and cost sensitivity, including PBS versus private scripts, shape adherence decisions and brand selection.

National Pharmacy Chains

Where can patients get their mirtazapine locally?

Mirtazapine, including Avanza and multiple generics, is widely stocked across major Australian chains such as Chemist Warehouse, Priceline and TerryWhite, as well as independent pharmacies.

Availability of orodispersible formulations varies by supplier and brand, so pharmacists may need to source specific strengths or formulations on request.

Online Pharmacy Growth And Telehealth E-Scripts

How are telehealth and online pharmacies changing access?

Telehealth and electronic prescribing have increased online dispensing, making it easier for rural patients to obtain mirtazapine with a valid prescription.

Pharmacists recommend in-person counselling when initiating therapy to discuss sedation, falls risk and dose titration.

Our online pharmacy offers discreet shipping across Australia with standard delivery times noted in the delivery table below.

PBS Vs Private Cost Comparisons

How much will mirtazapine cost me?

PBS-subsidised scripts substantially lower out-of-pocket costs for eligible patients compared with private prescriptions that attract full pharmacy pricing.

Price sensitivity is common in Australia, and many patients request generics from manufacturers such as Teva and Sandoz to reduce cost.

Occasional rural supply interruptions can affect availability of specific brands or orodispersible tablets.

Comparison (PBS Vs Non-PBS Options)

What are alternative antidepressant choices on PBS?

Common PBS-subsidised antidepressants include sertraline, escitalopram and venlafaxine, with mirtazapine used where sedation or appetite effects are desirable.

Non-PBS brands and private options such as Remeron or imported generics may be available at higher cost.

Pros And Cons Checklist

How does mirtazapine compare to other options?

Pros: rapid sedative benefit, low sexual dysfunction, appetite stimulation useful in cachexia.

Cons: weight gain, daytime sedation and fall risk, rare haematologic events.

SSRIs (sertraline, escitalopram) offer less sedation and broader anxiety indications but have higher sexual side-effect rates.

SNRIs (venlafaxine, duloxetine) suit severe depression and pain comorbidity but carry withdrawal and cardiovascular considerations.

Trazodone is commonly used for sleep but has inconsistent antidepressant efficacy compared with mirtazapine.

TGA Approval Framework

How does regulatory oversight operate in Australia?

Mirtazapine is TGA-approved for major depressive disorder and is prescription-only in Australia.

The TGA monitors adverse events and issues safety communications when signals such as falls or severe sedation require action.

Multiple manufacturers supply the Australian market, including local repackers and generics from Teva, Sandoz and others.

PBS Subsidy Process

How does mirtazapine get onto the PBS?

PBS listing requires evidence of clinical effectiveness and cost-effectiveness, and eligibility for subsidy depends on indication and prescriber status.

PBS utilisation data from 2021–2023 inform both supply planning and safety surveillance, and clinicians must meet documentation requirements for subsidised prescribing.

Consolidated FAQ

Will mirtazapine make me gain weight?

Many patients experience increased appetite and weight gain; discuss diet, exercise and dose options with your pharmacist or prescriber.

Can I drink alcohol while on mirtazapine?

Avoid or limit alcohol because it increases sedation and fall risk; speak to your pharmacist or doctor for personalised advice.

How quickly does it work?

Sleep and sedation effects often appear within 1–2 weeks, and full antidepressant effect typically takes 4–6 weeks.

Is it on the PBS and cheap?

Mirtazapine is TGA-approved and appears in PBS datasets; PBS scripts usually reduce cost for eligible patients compared with private prescriptions.

What if I miss a dose?

Take the missed dose when you remember unless it is close to your next dose; do not double up. Seek urgent care for suspected overdose.

Visual Guide

What illustrations should pharmacists and patients find useful?

Infographic 1 — PBS Pricing Flowchart: show private price versus PBS concession and general patient co-payment, include common brands such as Avanza and major generics, and list tablet strengths 15 mg, 30 mg and 45 mg.

Infographic 2 — Pharmacy Distribution Map: display national coverage of major chains (Chemist Warehouse, Priceline, TerryWhite), telehealth and e-script growth into rural zones, and icons indicating orodispersible availability.

Infographic 3 — Side-Effect Timeline: early (1–2 weeks) sedation and sleep improvement; medium (weeks–months) weight gain; long-term monitoring points such as CBC if symptomatic and liver tests if clinically indicated.

Design Notes: use Australian currency and PBS co-payment figures, include a TGA approval badge and highlight pharmacist counselling touchpoints.

Household Storage Under Australian Climate

How should patients store mirtazapine at home?

Store tablets at 15–30°C and protect them from moisture and direct sunlight.

In hot Australian summers avoid leaving medications in cars or bathrooms where temperature and humidity can damage them.

Keep medicines in their original packaging to preserve expiry and batch information and store them securely away from children and pets.

Cold-Chain Logistics For Pharmacies

Do pharmacies need special storage or transport?

Finished mirtazapine tablets and orodispersible tablets do not require cold chain; ambient transport and warehousing are sufficient.

During extreme heat events, pharmacies should avoid blister pack overheating which can affect disintegration of orodispersible tablets.

Maintain first-in, first-out inventory practices to manage multiple manufacturers and to reduce the risk of dispensing expired product.

Pharmacist Counselling Style In Australia

What should pharmacists tell patients starting mirtazapine?

Explain prescription status and PBS cost implications and advise bedtime dosing to use the sedative effect safely.

Warn about morning sedation and fall risk, and counsel about alcohol avoidance and interactions with other sedatives.

Set expectations: sleep benefits may appear in 1–2 weeks and full antidepressant effects in 4–6 weeks.

Advise regular weight monitoring, basic diet and exercise strategies, and when to seek medical review for severe side effects or suicidal thoughts.

National Health Authority Recommendations

Which guidelines support safe use?

Follow the TGA product information and PBS restrictions where applicable, and use the Pharmaceutical Society of Australia counselling frameworks for psychotropic medicines.

Collaborate with GPs and psychiatrists for patients with bipolar disorder risk, pregnancy considerations or complex comorbidity, and document counselling and follow-up, especially for older or rural patients.

Delivery Across Australia

Will I Need A Prescription To Order?

How do legal and practical access work in Australia?

Mirtazapine is prescription-only (S4) in Australia and should be supplied with a valid prescription in accordance with TGA and PBS rules.

Telehealth e-scripts make access easier for rural patients, but pharmacists advise initial counselling in person where possible before starting a sedating medicine.

Practical Counselling Phrases For Pharmacists

Which short scripts help patient safety?

"Take this at bedtime to reduce daytime drowsiness."

"Avoid alcohol while you are taking this medicine."

"Monitor your weight and report significant increases over weeks to months."

"If you feel unusually restless or have suicidal thoughts, seek medical help immediately."

Closing Notes For Clinicians And Patients

What are the takeaways for everyday practice?

Mirtazapine is a well-established antidepressant option that offers rapid sleep benefits and a low sexual side-effect profile compared with many SSRIs.

Trade-offs include weight gain and sedation, which are particularly relevant in older adults where falls are a real concern.

Start low and titrate cautiously, use PBS criteria where subsidy is needed, and document counselling and follow-up for safe ongoing use.

For brand or strength preferences such as Avanza 15 mg, Avanza 30 mg or Avanza 45 mg, pharmacists can suggest generics from Teva or Sandoz to reduce cost if suitable.